chitosan has been researched along with Carcinoma, Ovarian Epithelial in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, HJ; Byeon, Y; Han, HD; Jung, ID; Kang, TH; Kim, GH; Kim, MG; Lee, JM; Lee, JW; Lee, YJ; Park, YM; Park, YY; Shin, BC; Sood, AK; Wi, TI; Won, JE | 1 |
1 other study(ies) available for chitosan and Carcinoma, Ovarian Epithelial
| Article | Year |
|---|---|
Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Ovarian Epithelial; Cell Line; Cell Line, Tumor; Cell Proliferation; Chitosan; Drug Delivery Systems; Endothelial Cells; Female; Gene Silencing; Human Umbilical Vein Endothelial Cells; Humans; Hyaluronan Receptors; Hyaluronic Acid; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasm Proteins; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Particle Size; Receptors, Cell Surface; RNA, Messenger; RNA, Small Interfering; Xenograft Model Antitumor Assays | 2018 |